Search alternatives:
"correspondingly decrease" » "corresponding decrease" (Expand Search), "corresponding increase" (Expand Search), "corresponding case" (Expand Search)
"corresponding rates" » "corresponding models" (Expand Search), "corresponding parameters" (Expand Search), "corresponding time" (Expand Search)
Showing 1 - 20 results of 43 for search '(("correspondingly decrease") OR ("corresponding rates"))', query time: 0.17s Refine Results
  1. 1
    Impact of changes in on pharmaceutical pricing and profits.

    Impact of changes in on pharmaceutical pricing and profits. by Yan Wen (416285)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 2
    Multi-channel pharmaceutical supply chain model architecture.

    Multi-channel pharmaceutical supply chain model architecture. by Yan Wen (416285)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 3
    Comparison among related studies.

    Comparison among related studies. by Yan Wen (416285)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 4
    Impact of changes in health insurance reimbursement rates on pharmaceutical pricing and profits.

    Impact of changes in health insurance reimbursement rates on pharmaceutical pricing and profits. by Yan Wen (416285)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 5
    Impact of changes in on pharmaceutical pricing and profits.

    Impact of changes in on pharmaceutical pricing and profits. by Yan Wen (416285)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 6
    Impact of changes in on pharmaceutical pricing and profits.

    Impact of changes in on pharmaceutical pricing and profits. by Yan Wen (416285)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 7
    Impact of changes in competitive strength of direct marketing channels on pharmaceutical pricing and profits.

    Impact of changes in competitive strength of direct marketing channels on pharmaceutical pricing and profits. by Yan Wen (416285)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 8
    Symbols and meanings.

    Symbols and meanings. by Yan Wen (416285)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 9
    Impact of changes in competitive strength of online channels on pharmaceutical pricing and profits.

    Impact of changes in competitive strength of online channels on pharmaceutical pricing and profits. by Yan Wen (416285)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 10
    Functional enzyme at steady state over flow rate.

    Functional enzyme at steady state over flow rate. by Fabian Santiago (8384421)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 11
    Estimated rate and dissociation constants.

    Estimated rate and dissociation constants. by Fabian Santiago (8384421)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  12. 12
    Functional enzyme over time by inhibition pathway.

    Functional enzyme over time by inhibition pathway. by Fabian Santiago (8384421)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  13. 13
    Inhibition of factor X activation is weak in the absence of TFPI.

    Inhibition of factor X activation is weak in the absence of TFPI. by Fabian Santiago (8384421)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  14. 14
    Experimental measurements and uncertainty in model predictions of factor X activation.

    Experimental measurements and uncertainty in model predictions of factor X activation. by Fabian Santiago (8384421)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  15. 15
    Alternative model without reaction 7: Estimated rate and dissociation constants.

    Alternative model without reaction 7: Estimated rate and dissociation constants. by Fabian Santiago (8384421)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  16. 16
    Proposed mechanisms of TFPI inhibition of factor X activation.

    Proposed mechanisms of TFPI inhibition of factor X activation. by Fabian Santiago (8384421)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  17. 17
    Inhibition of factor X activation under flow.

    Inhibition of factor X activation under flow. by Fabian Santiago (8384421)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  18. 18
    The global numbers of prevalent cases (A), incident cases (B), deaths (C), DALYs (D), and corresponding rates of chronic obstructive pulmonary disease per 100,000 population in older adults, by age and sex in 2021.

    The global numbers of prevalent cases (A), incident cases (B), deaths (C), DALYs (D), and corresponding rates of chronic obstructive pulmonary disease per 100,000 population in old... by Kaifang Meng (13848535)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 19
    Prevalence and EAPC of chronic obstructive pulmonary disease among adults aged ≥70 years at the global and regional levels, from 1990 to 2021.

    Prevalence and EAPC of chronic obstructive pulmonary disease among adults aged ≥70 years at the global and regional levels, from 1990 to 2021. by Kaifang Meng (13848535)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 20
    Trends of death rates due to chronic obstructive pulmonary disease attributable to each risk factor among adults aged ≥70 years in 5 sociodemographic index regions, from 1990–2021.

    Trends of death rates due to chronic obstructive pulmonary disease attributable to each risk factor among adults aged ≥70 years in 5 sociodemographic index regions, from 1990–2021.... by Kaifang Meng (13848535)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: